| Validating the Amyloid Cascade Through the Revised Criteria of Alzheimer's Association Workgroup 2024 for Alzheimer Disease | Neurology |  | | 2025 | 28 | 491 |
|
| Early-phase 18F-Flortaucipir tau-PET as a proxy of brain metabolism in Alzheimer’s disease: a comparison with 18F-FDG-PET and early-phase amyloid-PET | European journal of nuclear medicine and molecular imaging | | | 2025 | 26 | 242 |
|
| Is early-phase amyloid PET ready for use as neurodegeneration marker ? | Journal of Alzheimer's disease | | | 2025 | 15 | 167 |
|
| Clinical and molecular correlates of limbic age-related TDP-43 encephalopathy (LATE) 18F-FDG-PET pattern in amnestic mild cognitive impairment | European journal of nuclear medicine and molecular imaging | | | 2025 | 27 | 803 |
|
| Association of glial fibrillary acid protein, Alzheimer's disease pathology and cognitive decline | Brain | | | 2024 | 19 | 268 |
|
| A comparison of visual assessment and semi-quantification for the diagnostic and prognostic use of [18F]flortaucipir PET in a memory clinic cohort | European journal of nuclear medicine and molecular imaging | | | 2024 | 98 | 134 |
|
| A deep learning model for generating [18F]FDG PET Images from early-phase [18F]Florbetapir and [18F]Flutemetamol PET images | European journal of nuclear medicine and molecular imaging | | | 2024 | 144 | 155 |
|
| Mapping brain metabolism, connectivity and neurotransmitters topography in early and late onset dementia with lewy bodies | Parkinsonism & related disorders |  | | 2024 | 84 | 0 |
|
| Tracer-Separator : A Deep Learning Model for Brain PET Dual-Tracer (18F-FDG and Amyloid) Separation | Clinical nuclear medicine | | | 2024 | 73 | 832 |
|
| Distinctive clinical and imaging trajectories in SWEDD and Parkinson's disease patients | NeuroImage. Clinical | | | 2024 | 76 | 64 |
|
| The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline | Alzheimer's & dementia | | | 2024 | 141 | 280 |
|
| In Vivo Tau and Neurodegeneration Imaging in a Family With the Presenilin 1 Met146Leu Pathogenic Variant | Neurology | | | 2024 | 18 | 134 |
|
| Sex differences in brain metabolic connectivity architecture in probable dementia with Lewy bodies | Neurobiology of aging | | | 2023 | 113 | 0 |
|
| Sex differences in dementia with Lewy bodies: an imaging study of neurotransmission pathways | European journal of nuclear medicine and molecular imaging | | | 2023 | 126 | 136 |
|
| Early-phase 18F-Florbetapir and 18F-Flutemetamol images as proxies of brain metabolism in a memory clinic setting | The Journal of nuclear medicine | | | 2023 | 190 | 347 |
|
| Manual and semi-automated approaches to MIBG myocardial scintigraphy in patients with Parkinson's disease | Frontiers in medicine | | | 2022 | 127 | 162 |
|
| Brain Metabolism and Amyloid Load in Individuals With Subjective Cognitive Decline or Pre-Mild Cognitive Impairment | Neurology | | | 2022 | 169 | 294 |
|
